Nanoneuromedicine for management of neurodegenerative disorder

Nitin Dwivedi, Jigna Shah, Vijay Mishra, Murtaza M Tambuwala, Prashant Kesharwani

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Conventional drug delivery systems are inadequate in providing essential cyto-architecture restoration and connection patterns because of restrictions posed by the restrictive blood-brain barrier. Nanotechnological approaches involve various nano-sized carrier systems and other devices, which stimulate the action of therapeutic agents on molecular level and revolutionized the treatment and diagnosis of neurodegenerative disorders with minimal side effects. Over the conventional approaches, nanotechnological approaches have various promising strategies to cross blood brain barrier and increase the bioavailability of therapeutics in brain. This review article emphasizes the current and future utility of nano drug delivery systems for the treatment of various neurodegenerative disorders.
LanguageEnglish
Pages477-490
Number of pages13
JournalJournal of Drug Delivery Science and Technology
Volume49
Early online date21 Dec 2018
Publication statusE-pub ahead of print - 21 Dec 2018

Fingerprint

Neurodegenerative Diseases
Drug Delivery Systems
Blood-Brain Barrier
Therapeutics
Biological Availability
Equipment and Supplies
Brain

Keywords

  • Parkinson disease
  • Neurodegenerative disorder
  • Nanotechnology
  • Alzheimers-Disease

Cite this

Dwivedi, N., Shah, J., Mishra, V., Tambuwala, M. M., & Kesharwani, P. (2018). Nanoneuromedicine for management of neurodegenerative disorder. 49, 477-490.
Dwivedi, Nitin ; Shah, Jigna ; Mishra, Vijay ; Tambuwala, Murtaza M ; Kesharwani, Prashant. / Nanoneuromedicine for management of neurodegenerative disorder. 2018 ; Vol. 49. pp. 477-490.
@article{6653046289af4390a259933797ac7ddb,
title = "Nanoneuromedicine for management of neurodegenerative disorder",
abstract = "Conventional drug delivery systems are inadequate in providing essential cyto-architecture restoration and connection patterns because of restrictions posed by the restrictive blood-brain barrier. Nanotechnological approaches involve various nano-sized carrier systems and other devices, which stimulate the action of therapeutic agents on molecular level and revolutionized the treatment and diagnosis of neurodegenerative disorders with minimal side effects. Over the conventional approaches, nanotechnological approaches have various promising strategies to cross blood brain barrier and increase the bioavailability of therapeutics in brain. This review article emphasizes the current and future utility of nano drug delivery systems for the treatment of various neurodegenerative disorders.",
keywords = "Parkinson disease , Neurodegenerative disorder, Nanotechnology, Alzheimers-Disease",
author = "Nitin Dwivedi and Jigna Shah and Vijay Mishra and Tambuwala, {Murtaza M} and Prashant Kesharwani",
year = "2018",
month = "12",
day = "21",
language = "English",
volume = "49",
pages = "477--490",

}

Dwivedi, N, Shah, J, Mishra, V, Tambuwala, MM & Kesharwani, P 2018, 'Nanoneuromedicine for management of neurodegenerative disorder', vol. 49, pp. 477-490.

Nanoneuromedicine for management of neurodegenerative disorder. / Dwivedi, Nitin ; Shah, Jigna ; Mishra, Vijay; Tambuwala, Murtaza M; Kesharwani, Prashant.

Vol. 49, 21.12.2018, p. 477-490.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Nanoneuromedicine for management of neurodegenerative disorder

AU - Dwivedi, Nitin

AU - Shah, Jigna

AU - Mishra, Vijay

AU - Tambuwala, Murtaza M

AU - Kesharwani, Prashant

PY - 2018/12/21

Y1 - 2018/12/21

N2 - Conventional drug delivery systems are inadequate in providing essential cyto-architecture restoration and connection patterns because of restrictions posed by the restrictive blood-brain barrier. Nanotechnological approaches involve various nano-sized carrier systems and other devices, which stimulate the action of therapeutic agents on molecular level and revolutionized the treatment and diagnosis of neurodegenerative disorders with minimal side effects. Over the conventional approaches, nanotechnological approaches have various promising strategies to cross blood brain barrier and increase the bioavailability of therapeutics in brain. This review article emphasizes the current and future utility of nano drug delivery systems for the treatment of various neurodegenerative disorders.

AB - Conventional drug delivery systems are inadequate in providing essential cyto-architecture restoration and connection patterns because of restrictions posed by the restrictive blood-brain barrier. Nanotechnological approaches involve various nano-sized carrier systems and other devices, which stimulate the action of therapeutic agents on molecular level and revolutionized the treatment and diagnosis of neurodegenerative disorders with minimal side effects. Over the conventional approaches, nanotechnological approaches have various promising strategies to cross blood brain barrier and increase the bioavailability of therapeutics in brain. This review article emphasizes the current and future utility of nano drug delivery systems for the treatment of various neurodegenerative disorders.

KW - Parkinson disease

KW - Neurodegenerative disorder

KW - Nanotechnology

KW - Alzheimers-Disease

M3 - Article

VL - 49

SP - 477

EP - 490

ER -

Dwivedi N, Shah J, Mishra V, Tambuwala MM, Kesharwani P. Nanoneuromedicine for management of neurodegenerative disorder. 2018 Dec 21;49:477-490.